Natalizumab improves disability on the Multiple Sclerosis Functional Composite in a randomised, double-blind, placebo-controlled study of patients with relapsing multiple sclerosis

被引：0
|
作者：
Munschauer, F.
Giovannoni, G.
O'Connor, P. W.
Phillips, J. T.
Polman, C. H.
Pace, A.
Hyde, R.
Kim, R.
机构：
[1] Jacobs Neurol Inst, Buffalo, NY USA
[2] Barts & London Queen Marys Sch Med & Dent, London, England
[3] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[4] Multiple Sclerosis Ctr Texas Neurol, Dallas, TX USA
[5] VU Med Ctr, Amsterdam, Netherlands
[6] Biogen Idec Inc, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS | 2009年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S124 / S125
页数：2
相关论文
共 50 条
  • [21] Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
    Gold, Ralf
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Havrdova, Eva
    Montalban, Xavier
    Radue, Ernst-Wilhelm
    Stefoski, Dusan
    Robinson, Randy
    Riester, Katherine
    Rana, Jitesh
    Elkins, Jacob
    O'Neill, Gilmore
    [J]. LANCET, 2013, 381 (9884): : 2167 - 2175
  • [22] A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis
    Coe, Shelly
    Cossington, Jo
    Collett, Johnny
    Soundy, Andrew
    Izadi, Hooshang
    Ovington, Martin
    Durkin, Luke
    Kirsten, Maja
    Clegg, Miriam
    Cavey, Ana
    Wade, Derick T.
    Palace, Jacqueline
    DeLuca, Gabriele C.
    Chapman, Kim
    Harrison, Jane-Marie
    Buckingham, Elizabeth
    Dawes, Helen
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (05): : 507 - 513
  • [23] GLANCE: A double-blind, randomised, placebo-controlled, parallel-group safety study of natalizumab (Antegren) in combination with glatiramer acetate (Copaxone) in subjects with relapsing-remitting multiple sclerosis
    Goodman, A
    Bar-Or, A
    Miller, A
    Miller, D
    Panzara, M
    Rossman, H
    Schmierer, K
    Toal, M
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 176 - 177
  • [24] Clinical results from AFFIRM: A randomized, double-blind, placebo-controlled, multicenter trial to determine the efficacy and safety of natalizumab in patients with relapsing multiple sclerosis (MS)
    Polman, C
    O'Connor, P
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, D
    Phillips, JT
    Lublin, F
    Giovannoni, G
    Wajgt, A
    Lynn, F
    Toal, M
    Panzara, M
    [J]. NEUROLOGY, 2005, 64 (06) : A146 - A146
  • [25] A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis
    Vollmer, Timothy L.
    Robinson, Michael J.
    Risser, Richard C.
    Malcolm, Sandra K.
    [J]. PAIN PRACTICE, 2014, 14 (08) : 732 - 744
  • [26] Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
    Calabresi, Peter A.
    Radue, Ernst-Wilhelm
    Goodin, Douglas
    Jeffery, Douglas
    Rammohan, Kottil W.
    Reder, Anthony T.
    Vollmer, Timothy
    Agius, Mark A.
    Kappos, Ludwig
    Stites, Tracy
    Li, Bingbing
    Cappiello, Linda
    von Rosenstiel, Philipp
    Lublin, Fred D.
    [J]. LANCET NEUROLOGY, 2014, 13 (06): : 545 - 556
  • [27] Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study
    Etemadifar, Masoud
    Sayahi, Farnaz
    Abtahi, Seyed-Hossein
    Shemshaki, Hamidreza
    Dorooshi, Gholam-Ali
    Goodarzi, Mohammad
    Akbari, Mojtaba
    Fereidan-Esfahani, Mahboobeh
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (07) : 480 - 486
  • [28] Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study
    Fereidan-Esfahani, Mahboobeh
    Etemadifar, Masoud
    Sayahi, Farnaz
    Abtahi, Seyed-Hossein
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 936 - 936
  • [29] Aspirin for multiple sclerosis-related fatigue: Results of a double-blind, placebo-controlled study
    Wingerchuk, DM
    Benarroch, EE
    O'Brien, PC
    Keegan, BM
    Lucchinetti, CF
    Nose-Worthy, JH
    Weinshenker, BG
    Rodriguez, M
    [J]. NEUROLOGY, 2002, 58 (07) : A492 - A492
  • [30] Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
    Pantzaris, Marios C.
    Bakirtzis, Christos
    Grigoriadis, Nikolaos
    Hadjigeorgiou, Georgios
    Dardiotis, Efthimos
    Loucaides, George
    Ntzani, Evangelia
    Markozannes, Georgios
    Omorfos, Savvas
    Valsasina, Paola
    Messina, Roberta
    Preziosa, Paolo
    Rocca, Maria A.
    Patrikios, Ioannis
    [J]. BMJ NEUROLOGY OPEN, 2022, 4 (02)
12345